KOPRAN LTD Financial Ratios
KOPRAN · Healthcare · Current price ₹282.95
P/E ratio
53.1x
P/B ratio
2.1x
ROE
0.0%
ROCE
6.6%
Debt / Equity
0.29
Dividend yield
1.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 53.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 0.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 6.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.29 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with KOPRAN LTD's latest numbers.
KOPRAN LTD profitability
KOPRAN LTD generates a return on equity of 0.0% and a return on capital employed of 6.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.29 and a P/E of 53.1x, KOPRAN LTD is conservatively financed. Our overall business-quality score for the company is 2.8 / 10.
Understand the ratios
More on KOPRAN LTD
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.